Stanford University
Showing 1,291-1,300 of 1,633 Results
-
Sarah Arnold
Ph.D. Student in Bioengineering, admitted Autumn 2025
Masters Student in Bioengineering, admitted Summer 2026Current Research and Scholarly InterestsEngineering approaches for understanding and treatment of psychiatric disorders.
-
Bruce Arnow, Ph.D.
Professor of Psychiatry and Behavioral Sciences (General Psychiatry and Psychology - Adult)
Current Research and Scholarly InterestsCurrent research interests include treatment outcome for major depression, particularly treatment refractory and chronic forms of major depression, as well as mediators and moderators of outcome; the epidemiology of chronic pain and depression; relationships between child maltreatment and adult sequelae, including psychiatric, medical and health care utilization.
-
Katherine Arnow, MS
Biostatistician 3, Stanford-Surgery Policy Improvement Research and Education Center
BioKate is the senior biostatistician at the Stanford-Surgery Policy Improvement and Education Center in the Department of Surgery. Kate's degree is in epidemiology and she has a background in research and public health. Her research interests include surgical outcomes and health policy assessment.
-
Martijn Arns
Affiliate, Psych/Major Laboratories and Clinical & Translational Neurosciences Incubator
Visiting Scholar, Psych/Major Laboratories and Clinical & Translational Neurosciences IncubatorBioMartijn Arns, PhD, is an applied neuroscientist and entrepreneur with a longstanding focus on brain stimulation, neurofeedback/BCI, and medtech innovation, affiliated with the Stanford Brain Stimulation Lab and the Psychedelics and Consciousness Lab previously headed by Dr. Nolan Williams, dividing his time between Palo Alto and Nijmegen, the Netherlands.
In 2001, he founded the Brainclinics Foundation, a non-profit research institute dedicated to applied neuroscience from the clinic, to the clinic. His research and clinical work span interventional psychiatry, precision and stratified psychiatry, and novel interventions including rTMS for depression and OCD, TMS-induced Heart–Brain Coupling, neurofeedback, and psychedelics.
Dr. Arns has published over 190 scientific papers and holds four patents. He has successfully translated research into practice through multiple spin-off ventures. Beyond research and entrepreneurship, Dr. Arns contributes to the scientific community as associate editor for leading journals, organizer of international conferences, and board member of several professional organizations. He also advises medtech and AI start-ups and established companies, helping to advance translation and implementation in applied neuroscience.
